stockrowCoherus Oncology, Inc. (CHRS) vs Vivani Medical, Inc. (VANI)
- Coherus Oncology, Inc. CHRS 0.54 −6.90%
- Vivani Medical, Inc. VANI 0.85 −24.78%
Coherus Oncology, Inc. and Vivani Medical, Inc. are both Biotechnology companies. Vivani Medical, Inc. is the larger, with a market value of $101.9M against $90.0M — 1.1× the size. Coherus Oncology, Inc. grew revenue faster over the last twelve months: 44.4% against −51.0%. Vivani Medical, Inc. has the higher net margin (0.00% vs −253.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 18 metrics below, Vivani Medical, Inc. leads on 10 and Coherus Oncology, Inc. on 8.
Valuation
Profitability
| Metric | CHRS | VANI | Biotechnology median |
|---|---|---|---|
| Gross margin | 69.81% | 0.00% | 68.81% |
| Operating margin | (275.94%) | 0.00% | 0.00% |
| Net margin | (253.43%) | 0.00% | 0.00% |
| Free cash flow margin | (323.85%) | 0.00% | 0.00% |
| Return on equity | (240.54%) | (220.40%) | (50.30%) |
| Return on assets | (39.54%) | (74.60%) | (45.47%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack